Skip to main content
AAO-HNSF 2024 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Panel Presentations

Head and Neck Surgery

Controversies in Parotid Surgery: Is There Evidence, Part 1

Monday, September 30, 2024
8:00 AM – 9:00 AM EDT
Location: MBCC, 209
CME/MOC Credit: 1
Disclosure(s):
Samir S. Khariwala, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Kelly Michele Malloy, MD, MBA:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Karen Y. Choi, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Lisa Shnayder, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: This panel addresses controversial, but commonly encountered, issues in the management of benign and malignant parotid disease. We will review the data regarding (1) capsular dissection for tumors; (2) superficial versus total parotidectomy for both primary malignancy and cutaneous metastases; (3) indications for neck dissection with primary parotid malignancy; (4) Management of the facial nerve in the setting of malignancy and (5) Complication rates and management. This session will allow for audience interaction and appeal to general otolaryngologists, academicians, and trainees, in addition to the head and neck oncological surgeon. This two hour panel presentation will cover the topics above using a combination of didactics, audience response queries, and case-based examples.

Learning Objectives:

  1. Use an evidence-based framework to determine appropriate use of capsular dissection in parotid disease.
  2. Understand indications for superficial vs total parotidectomy as well as the use of neck dissection in parotid malignancy.
  3. Understand data-based approach for facial nerve management in malignancy and prevention/management of complications.

    Moderator(s)

  • SK

    Samir S. Khariwala, MD

    Professor and Chair
    University of Minnesota
    Edina, MN, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

    • Panelist(s)

  • Kelly Michele Malloy, MD, MBA

    Professor
    University of Michigan
    Ann Arbor, MI, United States

    Disclosure information not submitted.

  • Karen Y. Choi, MD

    Associate Professor
    MD Anderson Cancer Center
    Houston, TX, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

  • LS

    Lisa Shnayder, MD

    Professor
    Kansas University Physicians Inc
    Kansas City, KS, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.